Legend Biotech (NASDAQ:LEGN) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.07 by 100 percent. This is a 147.06 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $387.500 million which beat the analyst consensus estimate of $355.772 million by 8.92 percent. This is a 51.93 percent increase over sales of $255.058 million the same period last year.